Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancer
Thomais Vlachogianni,1 Konstantinos Fiotakis,1 Spyridon Loridas,1 Stamatis Perdicaris,2 Athanasios Valavanidis1 1Department of Chemistry, Free Radicals Research Group, 2Faculty of Pharmacy, Department of Pharmacognosy and Natural Product Chemistry, University of Athens, Athens, Greece Abstract: Engi...
Enregistré dans:
Auteurs principaux: | Vlachogianni T, Fiotakis K, Loridas S, Perdicaris S, Valavanidis A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8f1b91a9a596470b9c4957ee77b70bd2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer
par: Stasi I, et autres
Publié: (2014) -
Clinical potential of nintedanib for the second-line treatment of advanced non-small-cell lung cancer: current evidence
par: Rothschild SI
Publié: (2014) -
Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer
par: Mark A. Socinski, et autres
Publié: (2021) -
Lung cancer in women
par: Barrera-Rodriguez R, et autres
Publié: (2012) -
Hepatoid Adenocarcinoma of the Lung
par: Meihui Li, et autres
Publié: (2021)